End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.58 CNY | +1.93% |
|
+0.28% | -30.21% |
01/05 | Huluwa Pharmaceutical Gets Nod to Register Two Drugs | MT |
26/04 | Hainan Huluwa Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 2,468
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Respiratory Medicine
59.9
%
| 933 | 61.6 % | 1,140 | 59.9 % | +22.26% |
Digestive System Medicine
21.0
%
| 362 | 23.9 % | 400 | 21.0 % | +10.50% |
Other Drugs
11.4
%
| 92 | 6.1 % | 218 | 11.4 % | +135.87% |
Systemic Anti-infective Drugs
7.7
%
| 128 | 8.4 % | 147 | 7.7 % | +14.75% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 1,515 | 100.0 % | 1,905 | 100.0 % | +25.75% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jing Ping Liu
CEO | Chief Executive Officer | 54 | 01/07/01 |
Peng Xu
CHM | Chairman | 61 | 01/10/01 |
Hui Yu
DFI | Director of Finance/CFO | 40 | 08/22/08 |
Jun Ling Li
BRD | Director/Board Member | 56 | 01/18/01 |
Bao Kun Wan
BRD | Director/Board Member | 62 | 01/12/01 |
Ping Liu
BRD | Director/Board Member | 51 | 01/12/01 |
Hai Yan Wang
IRC | Investor Relations Contact | 37 | 01/20/01 |
Qing Tao Wang
SEC | Corporate Secretary | 42 | 01/15/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gui Hua Wang
BRD | Director/Board Member | 63 | 16/18/16 |
Jing Ping Liu
CEO | Chief Executive Officer | 54 | 01/07/01 |
Ping Liu
BRD | Director/Board Member | 51 | 01/12/01 |
Bao Kun Wan
BRD | Director/Board Member | 62 | 01/12/01 |
Hui Yu
DFI | Director of Finance/CFO | 40 | 08/22/08 |
Jun Ling Li
BRD | Director/Board Member | 56 | 01/18/01 |
Qi Bo Tang
BRD | Director/Board Member | 36 | 04/22/04 |
Shi Xian Wang
BRD | Director/Board Member | 48 | 04/22/04 |
Qiu Yun Liu
BRD | Director/Board Member | 45 | 04/22/04 |
Peng Xu
CHM | Chairman | 61 | 01/10/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 400,108,752 | 83,526,717 ( 20.88 %) | 0 | 20.88 % |
Company contact information
Hainan Huluwa Pharmaceutical Group Co., Ltd.
8, Yaogu 4th Road Phase II, Yaogu Industrial Park
570311, Haikou
+
http://www.huluwayaoye.com![address Hainan Huluwa Pharmaceutical Group Co., Ltd.(605199)](https://cdn.zonebourse.com/static/address/111379900.png)
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-30.21% | 585M | |
+48.79% | 781B | |
-7.23% | 350B | |
+19.43% | 330B | |
+7.18% | 293B | |
+17.08% | 248B | |
+0.12% | 221B | |
+11.42% | 217B | |
+4.53% | 162B | |
-3.92% | 157B |
- Stock Market
- Equities
- 605199 Stock
- Company Hainan Huluwa Pharmaceutical Group Co., Ltd.